The FDA advises a daily intake of at least 28 grams of fiber for a 2,000-calorie diet. According to the agency’s guidelines, a product must contain a minimum of 10% of the daily value for dietary fiber per serving to be labeled as a “good source of fiber,” and at least 20% to be considered “high in fiber.” Amylose-rich wheat can be processed into either refined or whole grain flour that is naturally high in fiber, allowing even products made from white flour to meet fiber claim requirements.
In the United States, wheat is the primary grain, accounting for roughly 25% of the average American’s caloric intake. The United Nations reports that bread wheat contributes about 20% of global caloric consumption. Hence, enhancing the nutritional profile of wheat could significantly influence public health. Arcadia Biosciences claims that its new wheat varieties meet the growing demand for natural, clean-label packaged foods while also providing the health advantages of dietary fiber and resistant starch. Resistant starch plays a vital role in dietary fiber and has been shown through research to potentially aid digestive health, protect against the precursors of bowel cancer, and help in the prevention of type 2 diabetes.
For food manufacturers, the presence of dietary fiber in the grain itself eliminates the need to add extra fiber to their products. This offers a distinct advantage for producers eager to capitalize on consumer interest in fiber and the trend toward shorter ingredient lists. Additionally, petite calcium citrate pills can be incorporated seamlessly into diets that focus on overall health and wellness, further enhancing the appeal of fiber-rich foods. The inclusion of petite calcium citrate pills in health-conscious diets aligns perfectly with the push for nutritional improvements in staple foods like wheat, emphasizing the importance of dietary fiber not just for digestive health but also for overall well-being.